Article

Prophylactic Therapy with Emicizumab in Patients with Hemophilia A: Benefits and Challenges

2023-09-21

Abstract excerpt

This study presents a transversal investigation, that we performed at Fundeni hospital, into the therapeutic benefits and efficacy of Emicizumab, a non-factor therapy, in the context of hemophilia A. Ten patients diagnosed with hemophilia A were closely monitored, using clinical and laboratory resources, during the course of Emicizumab treatment, with an average of 12.8 months. Among these patients, six exhibited...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dccd4b65-78a8-5efc-9841-2bd17010bf4d
DOI: 10.20944/preprints202309.1391.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prophylactic Therapy with Emicizumab in Patients with Hemophilia A: Benefits and ChallengesDOI 10.20944/preprints202309.1391.v1Read

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and ChallengesSemantic proximity Read

Diagnosis and management of hemophilia A and B.Semantic proximity Read

Acquired hemophilia A: Updated review of evidence and treatment guidance.Semantic proximity Read

In vitro evaluation of global coagulation potential in the copresence of emicizumab and warfarin in whole blood using rotational thromboelastometrySemantic proximity Read

Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.Semantic proximity Read

Navigation of the Hemophilia Drug Choice-Paralysis: A Quick User Guide to New and Existing TherapiesSemantic proximity Read

Haemophilia.Semantic proximity Read

Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products.Semantic proximity Read

Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?Semantic proximity Read

[Hemophilia B replacement therapy drugs].Semantic proximity Read

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read

Hemophilia: in review.Semantic proximity Read